|

Dual-target CAR-NK cells (EB-DT-CAR-NK) Clinical Trials

1 actively recruiting trial

Also known as: EB-DT-CAR-NK (Essen Biotech Dual-Target CAR-NK)

Pipeline

Phase 1/2: 1

Top Sponsors

  • Beijing Biotech1

Indications

  • Breast Cancer (Locally Advanced or Metastatic)1
  • Triple Negative Breast Cancer (TNBC)1
  • HER2-positive Breast Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.